Of skin cancer and aspirin

Regularly taking aspirin may reduce women’s risk of developing melanoma, the deadliest form of skin cancer, a study finds.

Researchers from the Stanford University School of Medicine looked at data on 60,000 American women between 50 and 79 years old over a period of 12 years, finding those who took aspirin regularly had a 21 percent lower risk of developing melanoma compared to women who did not take the anti-inflammatory, according to SFGate.com. Further, women who took aspirin for five years or more had up to a 30 percent reduction in risk.

The authors noted that the study did not meet the standards of a clinical trial, as the research involved self-reporting on the part of participants.